Concepedia

Scott Burkholz

SB

Statistics

Publications

7

Citations

190

H-Index

7

Active since

2020

Affiliations

Flow Pharma (United States)(Current)

Columbia University

Case Western Reserve University

Massachusetts General Hospital

Stanford University

Scott Burkholz is an author at Flow Pharma (United States) specializing in infectious diseases, immunology, and vaccinology.

ORCID

Publications per year

2020–2023

7

Publications

7

An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design

C.v. Herst, Scott Burkholz, John Sidney et al. · Vaccine · 2020 · 65 citations · Full text

, , +17

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques

Paul E. Harris, Trevor Brasel, Christopher Massey et al. · Vaccines · 2021 · 36 citations · Full text

, , +17

Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies

Suman Pokhrel, Benjamin R. Kraemer, Scott Burkholz et al. · Scientific Reports · 2021 · 21 citations · Full text

, , +17

Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans

Scott Burkholz, Suman Pokhrel, Benjamin R. Kraemer et al. · Infection Genetics and Evolution · 2021 · 20 citations · Full text

, , +17

An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design

CV Herst, Scott Burkholz, John Sidney et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 19 citations · Full text

, , +17

1–5 of 7